Bill Gates, a Billionaire, Says Covid-19 Drugs and Vaccines Should Not Go to ‘Highest Bidder’

Bill Gates, a Billionaire, Says Covid-19 Drugs and Vaccines Should Not Go to ‘Highest Bidder’
Microsoft founder Bill Gates said it's important for covid-19 treatments and vaccines to go where they're most needed and not just to the highest bigger. (Photo: Jack Taylor, Getty Images)

Microsoft founder Bill Gates, a billionaire, said a good and right thing on Saturday. Gates called on leaders to make sure that future covid-19 drugs and vaccines to the people and countries that need them most, and not just to the highest bidders.

Florida Records 15,000 New Covid-19 Cases in a Day, the Most for Any State During the Pandemic

Florida broke the nation’s covid-19 single-day case record on Sunday, reporting 15,299 new infections, the most new cases ever reported by a state during the pandemic. The news underscores the raging state of the coronavirus crisis in the U.S., proving once again that the virus will not simply “sort of...

Read more

Speaking at a virtual covid-19 conference hosted by the International AIDS Society, Gates highlighted a growing concern among international government and public health officials: Once there are drugs and vaccines, who will get them first? According to Gates, it’s important to consider not only who can pay for these treatments, but also who and where they’re needed most.

“If we just let drugs and vaccines go to the highest bidders instead of to the people and the places where they’re most needed, we’ll have a longer, more unjust, deadlier pandemic,” Gates said. “We need leaders to make these hard decisions about distributing based on equity, not just on market-driven factors.”

There is no doubt that Gates’ comments are the good and right thing to say and do. However, it also must be noted that it’s ironic that he’s the one speaking out about this issue, considering Microsoft’s history of using its market power to crush competitors. Nonetheless, apparently using power and money to get ahead is a very bad thing. How convenient.

Gates’ hypocrisy aside, making sure the neediest countries and people have access to future vaccines and drugs does seem like the decent thing to do in the face of a global public health emergency, but it’s unfortunately not clear that this will happen once scientists develop effective treatments.

In late June, for instance, the U.S. bought up almost the entire stock of remdesivir — one of the few drugs known to be effective in treating covid-19 — for the next three months. Leaving little for the rest of the world.

‘Airborne,’ ‘Asymptomatic,’ and Other Misunderstood Coronavirus Terms

Today, the World Health Organisation formally announced a change in its stance over very two important issues concerning covid-19. The organisation stated that people can spread the virus while asymptomatic and that airborne transmission of the virus is possible under certain circumstances, such as crowded rooms with little ventilation.

Read more

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for COVID-19,” Health and Human Services Secretary Alex Azar said. “To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for covid-19 and secure access to these options for the American people.”

Given the apparent lack of U.S. interest in distributing a future coronavirus vaccine in an equitable way, many global leaders worry that the president will start a global fight for the vaccine. Such a fight would leave poorer countries behind. China, which has a significant number of potential covid-19 vaccines in development, is also a concern.

Although Chinese President Xi Jinping has said that Chinese-developed vaccines would be a “global public good,” a June government white paper said that the vaccine would be a global public product “once it is developed and deployed in China,” per the Los Angeles Times.

The World Health Organisation is working on a proposal for a Global Allocation Framework for covid-19 products. A June briefing of the proposal stated that, given the ubiquitous nature of covid-19, all countries should receive an initial allocation as products become available.

“Eventually, prioritisation of geography and timing would be based on a risk assessment of countries’ vulnerability and covid-19 threat,” the document said.

In this context, the WHO defined “vulnerability” as the vulnerability of countries’ health systems and population factors. “Threat,” meanwhile, refers to the potential impact of covid-19 on countries.

They Will Never Be Held Responsible for the Havoc They Have Created

Are you a frontline worker dealing with new stresses or irresponsible management? Is working (or not working) from home starting to take a psychological toll? How are you coping with reopening? Submit a story using this Google form or send me an email with the subject line “My Covid Story” and...

Read more

Bottom line: This is an easy debate. Under no circumstances should economically disadvantaged people and countries should be left with zero access to covid-19 vaccines and treatments, or have to go to the back of the line, just because richer countries have the ability to pay for them. That would be immoral.